About: covid:0370abacf3b212bd6bded8f23c8c904000f6c2e6

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:0370abacf3b212bd6bded8f23c8c904000f6c2e6 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Ma, Yan Wang, Yong Guo, Hui Zhou, Jian He, Hongliang Wang, Jinquan Anhui, ; Com, Jinquan Fei, Mingming Lu, Zhaohui Wang, ) Wang, Yinzhong Xia, Daqing Xu, Yehong Yin, Yihong Zheng, Changcheng Zheng, Mao Zhu, Yuyou
is schema:about of	named entity 'JOURNAL ' named entity 'Patients' named entity 'Patients' named entity 'ADAPTED' named entity 'RISK' named entity 'ILLNESS SEVERITY' named entity 'EFFICIENT' named entity 'APPROACH' named entity 'N A' named entity 'EFFECTIVE' named entity 'STRATEGY' named entity 'LENGTH' covid:arg/0370abacf3b212bd6bded8f23c8c904000f6c2e6 named entity 'COVID-19' named entity 'IS A' named entity 'HOW' named entity 'ACCORDING' named entity 'USEFUL' named entity 'CONSENSUS' named entity 'SYMPTOMS' named entity 'TREATMENT' named entity 'TREAT' named entity 'ADAPTED' named entity 'PRE' named entity 'TREATMENT STRATEGY' named entity 'COVID-19' named entity 'CLEAR' named entity 'PAPER' named entity 'PATIENTS' named entity 'CHEST CT' named entity 'RECOVERY' named entity 'GUIDELINES ' named entity 'PATIENTS' named entity 'RISK' named entity 'PROOF' named entity 'recovery' named entity 'treat' named entity 'paper' named entity 'chest CT' named entity '1846' named entity 'COVID-19' named entity 'COVID-19' named entity 'China' named entity 'methylprednisolone' named entity 'vital signs' named entity 'clinical symptoms' named entity 'oxygen support' named entity 'COVID-19' named entity 'inflammatory' named entity 'COVID-19' named entity 'immune response' named entity 'lymphocytes' named entity 'clinical characteristics' named entity 'SARS-CoV-2' named entity 'RNA' named entity 'oxygen' named entity 'oxygen saturation' named entity 'chest CT' named entity 'IgG' named entity 'influenza viruses' named entity 'fever' named entity 'China' named entity 'influenza' named entity 'IgG antibody' named entity 'high fever' named entity 'COVID-19' named entity 'SARS' named entity 'antibody' named entity 'IgM antibodies' named entity 'coronavirus infection' named entity 'COVID' named entity 'coagulation' named entity 'Influenza' named entity 'Middle East' named entity 'central nervous system disease' named entity 'MERS' named entity 'coronavirus' named entity 'virus' named entity 'polymerase-chain-reaction' named entity 'dry cough' named entity 'morbidity' named entity 'oxygen support'

Attributes

Values

Creator

Ma, Yan
Wang, Yong
Guo, Hui
Zhou, Jian
He, Hongliang
Wang, Jinquan
Anhui, ;
Com, Jinquan
Fei, Mingming
Lu, Zhaohui
Wang, )
Wang, Yinzhong
Xia, Daqing
Xu, Yehong
Yin, Yihong
Zheng, Changcheng
Zheng, Mao
Zhu, Yuyou

is schema:about of

named entity 'JOURNAL '
named entity 'Patients'
named entity 'Patients'
named entity 'ADAPTED'
named entity 'RISK'
named entity 'ILLNESS SEVERITY'
named entity 'EFFICIENT'
named entity 'APPROACH'
named entity 'N A'
named entity 'EFFECTIVE'
named entity 'STRATEGY'
named entity 'LENGTH'
covid:arg/0370abacf3b212bd6bded8f23c8c904000f6c2e6
named entity 'COVID-19'
named entity 'IS A'
named entity 'HOW'
named entity 'ACCORDING'
named entity 'USEFUL'
named entity 'CONSENSUS'
named entity 'SYMPTOMS'
named entity 'TREATMENT'
named entity 'TREAT'
named entity 'ADAPTED'
named entity 'PRE'
named entity 'TREATMENT STRATEGY'
named entity 'COVID-19'
named entity 'CLEAR'
named entity 'PAPER'
named entity 'PATIENTS'
named entity 'CHEST CT'
named entity 'RECOVERY'
named entity 'GUIDELINES '
named entity 'PATIENTS'
named entity 'RISK'
named entity 'PROOF'
named entity 'recovery'
named entity 'treat'
named entity 'paper'
named entity 'chest CT'
named entity '1846'
named entity 'COVID-19'
named entity 'COVID-19'
named entity 'China'
named entity 'methylprednisolone'
named entity 'vital signs'
named entity 'clinical symptoms'
named entity 'oxygen support'
named entity 'COVID-19'
named entity 'inflammatory'
named entity 'COVID-19'
named entity 'immune response'
named entity 'lymphocytes'
named entity 'clinical characteristics'
named entity 'SARS-CoV-2'
named entity 'RNA'
named entity 'oxygen'
named entity 'oxygen saturation'
named entity 'chest CT'
named entity 'IgG'
named entity 'influenza viruses'
named entity 'fever'
named entity 'China'
named entity 'influenza'
named entity 'IgG antibody'
named entity 'high fever'
named entity 'COVID-19'
named entity 'SARS'
named entity 'antibody'
named entity 'IgM antibodies'
named entity 'coronavirus infection'
named entity 'COVID'
named entity 'coagulation'
named entity 'Influenza'
named entity 'Middle East'
named entity 'central nervous system disease'
named entity 'MERS'
named entity 'coronavirus'
named entity 'virus'
named entity 'polymerase-chain-reaction'
named entity 'dry cough'
named entity 'morbidity'
named entity 'oxygen support'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software